Debt to EBITDA ratio Analysis of Adial Pharmaceuticals Inc - Deep Dive
Debt to EBITDA of ADIL
Dec-230Excellent Debt to EBITDA | Dec-22-0.0045Very Poor Debt to EBITDA | Growth0% |
Debt to EBITDA Analysis of Adial Pharmaceuticals Inc
Debt to EBITDA Ratio of ADIL has grown by 0 % Compared to previous Financial Year. |
Debt to EBITDA Ratio with value of 0 was highest in Year Dec-23 in last Five Years. |
Debt to EBITDA Ratio with value of -0.0045 was lowest in Year Dec-22 in last Five Years. |
Latest Debt to EBITDA Ratio with value of 0 is Greater than Average Debt to EBITDA of -0.0014 in last five years. |
Other Debt to EBITDA Related Info of ADIL that may interest you.
Adial Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ADIL | 1.45 | 1.45 | 0 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..Debt to EBITDA Related Ratios
CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
Excellent Stability |
FY - Historical Debt to EBITDA of Adial Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
Debt to EBITDA | 0 | -0.0045 | -0.0026 | 0 | 0 | 0 | -0.693 |
Change | 0 % | -73.94 % | 0 % | -21.32 % |
FY Chart of Debt to EBITDA of Adial Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)